Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial Fibrillation

Publisher： Karger

E-ISSN： 1424-8840|30|4|219-224

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.4, 2001-01, pp. : 219-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly

By Berge Trygve   Ulimoen Sara R.   Enger Steve   Arnesen Harald   Seljeflot Ingebjørg   Tveit Arnljot  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 4, 2013-06 ,pp. : 326-333

Informa Healthcare

Access to resources Recommend Favorite

Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis

By Harley C.R.   Riedel A.A.   Hauch O.   Nelson M.   Wygant G.   Reynolds M.  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 215-222

Informa Healthcare

Access to resources Recommend Favorite

D-Dimer Levels in Combination with Clinical Risk Factors Can Effectively Predict Subsequent Thromboembolic Events in Patients with Atrial Fibrillation during Oral Anticoagulant Therapy

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Therapy for atrial fibrillation: new challenges

By Shantsila Eduard   Watson Timothy   Lip Gregory YH  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 445-448

Future Medicine

Access to resources Recommend Favorite

Assessment of endothelial (dys)function in atrial fibrillation

By Krishnamoorthy Suresh   Lim Sern   Lip Gregory  

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 576-590

Informa Healthcare

Access to resources Recommend Favorite